逸豪新材(301176.SZ):PCB產品可應用於腦機接口必要電子設備中,公司目前暫未生產腦機接口系統
格隆匯5月31日丨有投資者在投資者互動平台向逸豪新材(301176.SZ)提問,“銅箔與PCB哪一種是在腦機接口系統中使用的?貴公司生產這兩種產品有幾年了?”
公司回覆稱,印製電路板(PCB)作為現代各類電子設備中的關鍵電子元器件,廣泛應用於消費電子、5G通訊、物聯網、大數據、雲計算、人工智能、新能源汽車、工控醫療等眾多領域。PCB產品可應用於腦機接口必要電子設備中,公司目前暫未生產腦機接口系統。2021年第三季度公司PCB項目一期開始試生產,目前公司PCB業務尚處於爬坡階段。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.